Bethesda System for Cervical Cytology

The Bethesda System is the standardised terminology used to report cervical cytology results. Introduced in 1988 and revised in 2001 and 2014, it replaced inconsistent local terminologies with a uniform framework that classifies specimen adequacy, squamous and glandular abnormalities, and ancillary findings, allowing cytology reports to communicate reproducible, risk-based categories.

Definition

The Bethesda System is a standardised reporting framework for cervical (and other gynaecologic) cytology that records specimen adequacy and classifies epithelial cell abnormalities into defined squamous and glandular categories conveying associated risk of underlying intraepithelial neoplasia or carcinoma.

Scope

This topic covers the structure of a Bethesda report: the statement of specimen adequacy, the general categorisation, and the specific interpretive categories for squamous lesions (ASC-US, ASC-H, LSIL, HSIL, squamous cell carcinoma) and glandular lesions (AGC, AIS, adenocarcinoma). It is a reporting-terminology reference and does not prescribe individual patient management.

Core questions

• How does a Bethesda report communicate specimen adequacy and overall interpretation?
• What distinguishes the squamous interpretive categories ASC-US, ASC-H, LSIL, and HSIL?
• How do glandular categories (AGC, endocervical AIS) differ in meaning and follow-up risk?
• How reproducible are the morphologic thresholds between categories, especially ASC-US?

Key concepts

• Specimen adequacy and the transformation-zone component
• Negative for intraepithelial lesion or malignancy (NILM)
• ASC-US and ASC-H (atypical squamous cells)
• Low-grade and high-grade squamous intraepithelial lesion (LSIL, HSIL)
• Atypical glandular cells (AGC) and endocervical adenocarcinoma in situ
• Two-tiered squamous grading aligned with HPV biology
• Reproducibility and the ASC-US category

Mechanisms

Bethesda categories map morphologic change onto the biology of HPV-driven neoplasia. The two-tiered squamous scheme (LSIL versus HSIL) reflects the distinction between transient productive HPV infection and transforming infection with higher cancer risk. Indeterminate categories (ASC-US, ASC-H, AGC) flag cells that fall short of a definitive lesion but warrant risk stratification, often with HPV testing, because morphology alone is imperfectly reproducible (solomon-2002, cox-2003).

Clinical relevance

A Bethesda interpretation conveys an estimated risk of underlying precancer and is the entry point for triage and colposcopy decisions in screening programmes. This entry explains what the categories mean and how they relate to risk; it does not specify individual follow-up intervals, referral thresholds, or treatment.

History

The system was created at a 1988 National Cancer Institute workshop in Bethesda, Maryland, to standardise cervical cytology reporting and to replace the older Papanicolaou numeric classes. The 2001 revision formalised specimen-adequacy reporting and the ASC-US/ASC-H split and aligned cytologic with histologic terminology, and the 2014 update further refined criteria and incorporated the experience of liquid-based cytology and HPV co-testing (solomon-2002, nayar-wilbur-2015).

Debates

The reproducibility and clinical handling of ASC-US

ASC-US is the least reproducible Bethesda category, and how to triage it — reflex HPV testing, repeat cytology, or immediate colposcopy — has been a central question that shaped the evidence base for HPV-based triage.

Key figures

• Diane Solomon
• Robert Kurman
• Ritu Nayar
• David Wilbur
• Thomas Wright

Seminal works

• solomon-2002
• nayar-wilbur-2015

Frequently asked questions

What is the difference between LSIL and HSIL in the Bethesda System?

LSIL (low-grade squamous intraepithelial lesion) usually reflects transient, productive HPV infection with low cancer risk, whereas HSIL (high-grade) reflects transforming infection with substantially higher risk of progression to invasive cancer, which is why the two carry different levels of concern.

Why does the Bethesda System include 'atypical' categories like ASC-US?

Cytologic changes do not always meet the threshold for a definite lesion. The atypical categories acknowledge this uncertainty and flag specimens for further risk stratification, commonly with HPV testing, rather than forcing an over- or under-call.